Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Geriatr Phys Ther ; 37(4): 154-8, 2014.
Article in English | MEDLINE | ID: mdl-24534849

ABSTRACT

BACKGROUND AND PURPOSE: Musculoskeletal problems, including shoulder pain, are common in the general population and are often cited as reasons for physician visits. Although many risk factors for shoulder pain are postulated, the effects of shoulder pain on functional level and perceived quality of life are poorly characterized in older adults. In this study, we set out to determine the prevalence and impact of shoulder symptoms and dysfunction in an older adult veteran population. METHODS: A chart review, cross-sectional survey, and examination were performed. A sample of 93 individuals, aged 60 years or older, was recruited from a primary clinic outpatient waiting room at the Clement J. Zablocki VA Medical Center in Milwaukee, Wisconsin. Patients were asked about shoulder symptoms and self-assessed health and completed the Stanford Modified Health Assessment Questionnaire. A series of 3 shoulder maneuvers was used to assess shoulder mobility and pain. The presence of diabetes and statin use was documented. A more thorough chart review was performed on individuals who reported shoulder pain and disability. RESULTS: Severe shoulder pain was common in the study group, reported by 31% of all participants. Functional limitation measured by the Modified Health Assessment Questionnaire and answering "yes" to greater difficulty performing daily tasks was associated with reduced internal rotation, which was present in almost 36% of all participants. Symptoms were often bilateral. No statistically significant risk factors emerged in this small sample, but suggestive trends were apparent. Interestingly, few patients reported discussing these problems with their providers, and shoulder-related problems were documented in only 10% of corresponding problem lists of symptomatic patients. CONCLUSIONS: With an aging population, the high prevalence of shoulder pain may have considerable impact on public health. It will become increasingly important to define risk factors, delineate etiologies, and devise new management strategies for patients with symptomatic shoulder disease.


Subject(s)
Shoulder Pain/epidemiology , Age Factors , Aged , Aged, 80 and over , Aging , Analgesics/therapeutic use , Body Mass Index , Cross-Sectional Studies , Diabetes Mellitus/epidemiology , Female , Geriatric Assessment , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Male , Middle Aged , Prevalence , Shoulder Pain/drug therapy , Time Factors
2.
Connect Tissue Res ; 53(6): 535-41, 2012.
Article in English | MEDLINE | ID: mdl-22891926

ABSTRACT

RATIONALE: Diabetic tendinopathy is characterized by increased stiffness, thickness, and excess calcification of affected tendons. We investigated the hypothesis that proteoglycans (PGs), as key regulators of tendon structure and calcification, are altered in diabetic tendons. METHODS: Adult porcine patellar tendons were incubated in iso-osmolar media with high or normal glucose levels for 2 weeks. The PG fraction was isolated and analyzed. Protein and mRNA levels of five PGs were measured. PG production was assessed in primary tenocyte monolayers by (35)S-sulfate labeling in high and normal glucose conditions with and without exposure to advanced glycation end-products (AGEs). Levels of transforming growth factor ß, which commonly mediates some effects of hyperglycemia, were also measured and the effects of free radical scavengers on (35)S-sulfate incorporation were determined. RESULTS: PG levels were significantly decreased in tendons exposed to high glucose media compared with tendons in iso-osmolar control media. Relative quantities of individual PGs were unchanged by exposure to hyperglycemia and mRNAs for PGs were variably affected. High glucose media decreased PG production by tenocytes as measured by (35)S-sulfate labeling, whereas AGE-modified type I collagen and free radical scavengers had no effects. Hyperglycemic conditions increased levels of transforming growth factor ß1 in an AGE-independent manner. CONCLUSIONS: Hyperglycemia produces a reduction in PG levels related to decreased synthesis or sulfation of glycosaminoglycans, which may contribute to the tendon pathology observed clinically in diabetes.


Subject(s)
Diabetes Complications/metabolism , Glycation End Products, Advanced/metabolism , Hyperglycemia/metabolism , Peptidoglycan/metabolism , Tendinopathy/metabolism , Tendons/metabolism , Animals , Collagen Type I/metabolism , Diabetes Complications/pathology , Hyperglycemia/pathology , Organ Culture Techniques , Swine , Tendinopathy/pathology , Tendons/pathology , Transforming Growth Factor beta/metabolism
3.
J Investig Med ; 57(2): 460-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19127169

ABSTRACT

OBJECTIVES: Tendon abnormalities, such as increased stiffness, thickness, and excess calcification, occur commonly in patients with diabetes mellitus and cause considerable disability. These changes are frequently attributed to increased cross-linking of extracellular matrix components by advanced glycation end-products (AGEs). However, cellular effects of AGEs, such as increased activity of the cross-linking transglutaminase (Tgase) enzymes, could also contribute to altered tissue biomechanics and calcification in diabetic tendons. We determined the effect of AGE-modified protein on tenocyte Tgase activity. RESEARCH DESIGN AND METHODS: Primary porcine tenocytes were exposed to N- carboxymethyl-lysine (CML)-modified type I collagen in high or normal glucose media. Protein and mRNA levels of the Tgase enzymes and Tgase activity levels were measured, as were markers of apoptosis. We also determined the effect of antioxidants on CML-collagen mediated Tgase activity. RESULTS: Carboxymethyl-lysine-collagen increased Tgase activity in tenocytes 2.3- to 5.6-fold over unmodified collagen controls in both normal and high glucose media, without altering enzyme protein levels. Anti-oxidant treatment reduced the effect of CML-collagen on Tgase activity. Deoxyribonucleic acid laddering and annexin V protein levels were not altered by CML-collagen exposure. CONCLUSIONS: Carboxymethyl-lysine-collagen increased Tgase activity in tenocytes, likely posttranslationally. Increased levels of Tgase-mediated cross-links may contribute to the excess calcification and biomechanical pathology seen in diabetic tendons.


Subject(s)
Glycation End Products, Advanced/metabolism , Tendons/enzymology , Transglutaminases/metabolism , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Gene Expression Regulation, Enzymologic/drug effects , Lysine/analogs & derivatives , Lysine/pharmacology , RNA, Messenger/metabolism , Stifle/metabolism , Swine , Tendons/drug effects , Tetrazolium Salts/metabolism , Thiazoles/metabolism , Transglutaminases/genetics
4.
Curr Opin Rheumatol ; 21(1): 50-4, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19077719

ABSTRACT

PURPOSE OF REVIEW: This review summarizes recent advances in the field of diabetes and rheumatic disease. These conditions exert a significant healthcare burden on our society and much remains to be learned regarding their pathophysiology and treatment. RECENT FINDINGS: We summarize new insights into diabetes and its association with osteoarthritis, rheumatoid arthritis, carpal tunnel syndrome, osteoporosis, diffuse idiopathic skeletal hyperostosis, crystalline arthropathy, neuropathic arthropathy, and tendinopathy. Diabetes has major effects on connective tissues, which have significant impact on both the development and outcome of these diseases of cartilage, bone, ligament, and tendon. An improved understanding of the mechanisms through which diabetes alters connective tissue metabolism should lead to better preventive and therapeutic interventions. SUMMARY: Incremental progress has been made in understanding the interactions between diabetes and common musculoskeletal syndromes. Although this review highlights exciting areas of future interest, more work in this field is certainly warranted.


Subject(s)
Arthritis/physiopathology , Connective Tissue/physiopathology , Diabetes Complications/physiopathology , Rheumatic Diseases/physiopathology , Arthritis/immunology , Arthritis/metabolism , Cartilage/immunology , Cartilage/metabolism , Cartilage/physiopathology , Connective Tissue/immunology , Connective Tissue/metabolism , Diabetes Complications/immunology , Diabetes Complications/metabolism , Gout/immunology , Gout/metabolism , Gout/physiopathology , Humans , Hyperostosis/immunology , Hyperostosis/metabolism , Hyperostosis/physiopathology , Rheumatic Diseases/immunology , Rheumatic Diseases/metabolism , Tendinopathy/immunology , Tendinopathy/metabolism , Tendinopathy/physiopathology , Tendons/immunology , Tendons/metabolism , Tendons/physiopathology
5.
Arthritis Rheum ; 58(10): 3270-4, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18821676

ABSTRACT

OBJECTIVE: Basic calcium phosphate (BCP) crystals are common components of osteoarthritis (OA) synovial fluid. Progress in understanding the role of these bioactive particles in clinical OA has been hampered by difficulties in their identification. Tetracyclines stain calcium phosphate mineral in bone. The aim of this study was to investigate whether tetracycline staining might be an additional or alternative method for identifying BCP crystals in synovial fluid. METHODS: A drop of oxytetracycline was mixed with a drop of fluid containing synthetic or native BCP, calcium pyrophosphate dihydrate (CPPD), or monosodium urate (MSU) crystals and placed on a microscope slide. Stained and unstained crystals were examined by light microscopy, with and without a portable broad-spectrum ultraviolet (UV) pen light. A small set of characterized synovial fluid samples were compared by staining with alizarin red S and oxytetracycline. Synthetic BCP crystals in synovial fluid were quantified fluorimetrically using oxytetracycline. RESULTS: After oxytetracycline staining, synthetic and native BCP crystals appeared as fluorescent amorphous aggregates under UV light. Oxytetracycline did not stain CPPD or MSU crystals or other particulates. Oxytetracycline staining had fewer false-positive test results than did alizarin red S staining and could provide estimates of the quantities of synthetic BCP crystals in synovial fluid. CONCLUSION: With further validation, oxytetracycline staining may prove to be a useful adjunct or alternative to currently available methods for identifying BCP crystals in synovial fluid.


Subject(s)
Calcium Pyrophosphate/analysis , Oxytetracycline , Synovial Fluid/chemistry , Animals , Feasibility Studies , Histocytochemistry/methods , Humans , Microscopy, Ultraviolet/instrumentation , Sus scrofa
SELECTION OF CITATIONS
SEARCH DETAIL
...